Novel Outreach Program and Practical Strategies for Patients with Parkinsonism in the COVID-19 Pandemic1

Sennott, Brianna; Woo, Katheryn; Hess, Serena P.; Mitchem, Daniela; Klostermann, Ellen C.; Myrick, Erica; Anderson, Sharlet; Savica, Rodolfo; Fleisher, Jori

doi:10.3233/jpd-202156

Cited by 11 publications

(14 citation statements)

References 38 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Teleconsultations also offer opportunities to provide proactive care, i.e., aiming to identify new medical issues early on so these can be managed timely, thereby preventing avoidable disability and reducing unnecessary costs. An illustrative example is a proactive outreach program that targeted homebound and vulnerable persons with advanced PD and related disorders [ 25 ▪ ]. A nurse or social worker proactively called these patients to discuss topics such as home safety, physical and mental wellbeing, medical care provisions, and also lockdown restrictions or scheduling of healthcare appointments.…”

Section: Teleconsultationmentioning

confidence: 99%

“…A nurse or social worker proactively called these patients to discuss topics such as home safety, physical and mental wellbeing, medical care provisions, and also lockdown restrictions or scheduling of healthcare appointments. Patients and caregivers reported that the program made them feel safe and supported [ 25 ▪ ]. Whether this proactive approach actually avoids medical deterioration and prevents e.g.…”

Section: Teleconsultationmentioning

confidence: 99%

See 1 more Smart Citation

The state of telemedicine for persons with Parkinson's disease

Bergh

Bloem

Meinders³

et al. 2021

Current Opinion in Neurology

View full text Add to dashboard Cite

Purpose of review The COVID-pandemic has facilitated the implementation of telemedicine in both clinical practice and research. We highlight recent developments in three promising areas of telemedicine: teleconsultation, telemonitoring, and teletreatment. We illustrate this using Parkinson's disease as a model for other chronic neurological disorders. Recent findings Teleconsultations can reliably administer parts of the neurological examination remotely, but are typically not useful for establishing a reliable diagnosis. For follow-ups, teleconsultations can provide enhanced comfort and convenience to patients, and provide opportunities for blended and proactive care models. Barriers include technological challenges, limited clinician confidence, and a suboptimal clinician-patient relationship. Telemonitoring using wearable sensors and smartphone-based apps can support clinical decision-making, but we lack large-scale randomized controlled trials to prove effectiveness on clinical outcomes. Increasingly many trials are now incorporating telemonitoring as an exploratory outcome, but more work remains needed to demonstrate its clinical meaningfulness. Finding a balance between benefits and burdens for individual patients remains vital. Recent work emphasised the promise of various teletreatment solutions, such as remotely adjustable deep brain stimulation parameters, virtual reality enhanced exercise programs, and telephone-based cognitive behavioural therapy. Personal contact remains essential to ascertain adherence to teletreatment. Summary The availability of different telemedicine tools for remote consultation, monitoring, and treatment is increasing. Future research should establish whether telemedicine improves outcomes in routine clinical care, and further underpin its merits both as intervention and outcome in research settings.

show abstract

Section: Teleconsultationmentioning

confidence: 99%

Section: Teleconsultationmentioning

confidence: 99%

The state of telemedicine for persons with Parkinson's disease

Bergh

Bloem

Meinders³

et al. 2021

Current Opinion in Neurology

View full text Add to dashboard Cite

show abstract

“… Rhodes et al (2020) [ 84 ] Study is a recommendation (out of study design). Sennott et al (2020) [ 85 ] Study is a commentary (out of study design). Speretta and Leite (2020) [ 86 ] Study is an editorial (out of study design).…”

Section: Table A1mentioning

confidence: 99%

Physical Activity, Sedentary Behavior and Well-Being of Adults with Physical Disabilities and/or Chronic Diseases during the First Wave of the COVID-19 Pandemic: A Rapid Review

Boer

Hoekstra

Huetink

et al. 2021

IJERPH

View full text Add to dashboard Cite

Background: People with physical disabilities and/or chronic diseases report lower levels of physical activity and well-being than the general population, which potentially is exacerbated through the COVID-19 pandemic. This study explored the international literature on physical activity, sedentary behavior and well-being in adults with physical disabilities and/or chronic diseases during the first wave of the pandemic. Method: In a rapid review, we included studies reporting on physical activity, sedentary behavior and/or well-being in adults with physical disabilities and/or chronic diseases. Four databases (Pubmed, CINAHL, PsycInfo, Embase) were searched for studies published until 30 September 2020. Results: We included twenty-nine studies involving eleven different types of disabilities or health conditions from twenty-one different countries. Twenty-six studies reported on physical activity, of which one reported an increase during the COVID-19 pandemic, four studies reported no difference, and twenty-one studies reported a decrease. Thirteen studies reported a decline in well-being. Only one study measured sedentary behavior, reporting an increase. Conclusion: Despite the variety in methods used, almost all studies reported negative impacts on physical activity and well-being in people with physical disabilities and/or chronic disease during the first wave of the pandemic. These findings highlight the importance of supporting this population, especially in times of crisis.

show abstract

“…However, the aforementioned neuropathological data from autopsy studies call this hypothesis into question [8,9]. Regardless of such hypothesized protective effects, PD patients are nevertheless more vulnerable to complications following respiratory infections, and odds for their hospitalization or development of other comorbidities are higher than the general population [60]. Furthermore, parkinsonian symptoms after viral respiratory infections may hint us toward the less-known sides of the disease etiology and pathogenesis [61].…”

Section: Chorea Associated With Covid-19mentioning

confidence: 99%

Movement Disorders Associated with COVID-19

Salari

Harofteh

Etemadifar

et al. 2021

Parkinson's Disease

View full text Add to dashboard Cite

As neurological complications associated with COVID-19 keep unfolding, the number of cases with COVID-19-associated de novo movement disorders is rising. Although no clear pathomechanistic explanation is provided yet, the growing number of these cases is somewhat alarming. This review gathers information from 64 reports of de novo movement disorders developing after/during infection with SARS-CoV-2. Three new cases with myoclonus occurring shortly after a COVID-19 infection are also presented. Treatment resulted in partial to complete recovery in all three cases. Although the overall percentage of COVID-19 patients who develop movement disorders is marginal, explanations on a probable causal link have been suggested by numerous reports; most commonly involving immune-mediated and postinfectious and less frequently hypoxic-associated and ischemic-related pathways. The current body of evidence points myoclonus and ataxia out as the most frequent movement disorders occurring in COVID-19 patients. Some cases of tremor, chorea, and hypokinetic-rigid syndrome have also been observed in association with COVID-19. In particular, parkinsonism may be of dual concern in the setting of COVID-19; some have linked viral infections with Parkinson’s disease (PD) based on results from cerebrospinal fluid analyses, and PD is speculated to impact the outcome of COVID-19 in patients negatively. In conclusion, the present paper reviewed the demographic, clinical, and treatment-associated information on de novo movement disorders in COVID-19 patients in detail; it also underlined the higher incidence of myoclonus and ataxia associated with COVID-19 than other movement disorders.

show abstract

Novel Outreach Program and Practical Strategies for Patients with Parkinsonism in the COVID-19 Pandemic1

Cited by 11 publications

References 38 publications

The state of telemedicine for persons with Parkinson's disease

The state of telemedicine for persons with Parkinson's disease

Physical Activity, Sedentary Behavior and Well-Being of Adults with Physical Disabilities and/or Chronic Diseases during the First Wave of the COVID-19 Pandemic: A Rapid Review

Movement Disorders Associated with COVID-19

Contact Info

Product

Resources

About